Merck has reported results for the first quarter ended March 31, 2013.
The company has reported rise of 12.83% in its net profit at Rs 13.98 crore for the quarter ended March 31, 2013 as compared to Rs 12.39 crore for the same quarter in the previous year. Total income from operation of the company has increased by 24.37% at Rs 182.04 crore for quarter under review as compared to Rs 146.37 crore for the quarter ended March 31, 2012.
Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |